Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1466 of 5804
-
New balloon treatment for heart disease tested in first human study
Disease control OngoingThis prospective, single-arm, multi-center, safety and feasibility first-in-human study will evaluate the safety and feasibility of the SirPlux Duo™ Dual-API Coated PTCA Balloon Catheter to treat de-novo lesions between ≥2.0 and ≤4.0 mm in patients with symptomatic stable angina,…
Phase: NA • Sponsor: Advanced NanoTherapies • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New inhaled therapy targets lung scarring in early trial
Disease control CompletedThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of ARO-MMP7 in normal healthy volunteers (NHVs) and in participants with idiopathic pulmonary fibrosis (IPF). The study will initiate with NHVs receiving single asce…
Phase: PHASE1, PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New drug cocktail aims to stall colorectal cancer
Disease control OngoingThis is a Phase 1b/2 study to investigate the efficacy and safety of alcestobart (LBL-007) plus tislelizumab when administered in combination with bevacizumab plus fluoropyrimidine, and alcestobart in combination with bevacizumab plus fluoropyrimidine versus bevacizumab plus fluo…
Phase: PHASE1, PHASE2 • Sponsor: BeiGene • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Prostate cancer drug showdown: which is safer for the heart?
Disease control CompletedThis was a randomized study to evaluate the risk of major adverse cardiovascular events (MACE) for relugolix compared with leuprolide acetate. Enrollment in this study was discontinued by the Sponsor on 01 Dec 2023. In an effort to mitigate any treatment interruptions, actively e…
Phase: PHASE3 • Sponsor: Sumitomo Pharma America, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Study tests if flexible methadone pickups keep patients in treatment
Disease control Recruiting nowUsing a stepped-wedge randomized controlled trial, the study will test whether a clinic-level multidimensional intervention conducted in 36 opioid treatment programs (OTPs) will improve clinical decision making, regulatory confusion, legal liability concerns, capacity for clinica…
Phase: NA • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New implanted device aims to stop urgency incontinence
Disease control Recruiting nowA prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the eCoin® implanted tibial nerve stimulator in subjects with urgency urinary incontinence (UUI).
Phase: NA • Sponsor: Valencia Technologies Corporation • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Zapping the brain to zap migraines: new study tests 20-Day stimulation
Symptom relief Recruiting nowThis study investigates whether unilateral and bilateral non-invasive brain stimulation, given for 20 minutes/once per day for twenty days (M-F) can reduce migraine pain. Fourty patients will receive treatment (20 unilateral treatment, and 20 bilateral treatment), while twenty wi…
Phase: NA • Sponsor: University of Michigan • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
New RNA drug aims to reduce blood removal in polycythemia vera patients
Disease control OngoingThis is a Phase 1/2, multicenter study with an open-label dose escalation followed by a randomized placebo controlled and double-blind phase of SLN124 in adult patients with Polycythemia Vera (PV) to assess the safety, tolerability, efficacy, pharmacokinetic (PK), and Pharmacodyn…
Phase: PHASE1, PHASE2 • Sponsor: Silence Therapeutics plc • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New dissolving stent aims to prevent dangerous leaks after pancreatic surgery
Disease control CompletedThe aim of this randomized controlled study is to compare the efficacy of biodegradable internal pancreatic stenting versus no stenting in patients undergoing pancreatoduodenectomy (PD), focusing on a possible superiority association of the device in preventing clinically relevan…
Phase: NA • Sponsor: Ospedale San Raffaele • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
MRNA shingles vaccine trial ends early – what we know
⭐️ VACCINE ⭐️ TerminatedThe purpose of this clinical study is to learn about the safety, extent of the side effects (reaction to vaccine), and immune response (your immune system's reaction) of the study vaccine called Varicella Zoster Virus modRNA (VZV modRNA). We are seeking for healthy participants 5…
Phase: PHASE1, PHASE2 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:29 UTC
-
Could a statin tame fatty liver disease? new trial seeks answers
Disease control OngoingThe purpose of this research study is to determine whether the study drug, atorvastatin (Lipitor®), is safe and effective in improving the features of NASH.
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New therapy aims to ease anxiety and depression in LGBTQ+ community hit by pandemic
Symptom relief OngoingThe overall aim of this program of research is to improve the mental health of people who identify as LGBTQ+ by increasing their social support through a brief intervention. The purpose of the proposed project is to establish the effectiveness of our empirically-supported, brief …
Phase: PHASE2 • Sponsor: Brown University • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
New counseling approach helps zambians with HIV cut alcohol and boost viral control
Disease control CompletedThis study, which is part of the Zambia Alabama HIV Alcohol Comorbidities Program funded by NIH-NIAAA, is designed to examine the efficacy of brief and in-depth cognitive behavioral therapy-based interventions to address, unhealthy alcohol use, comorbid mental health symptoms, an…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New heart valve shows promise in tight aortic stenosis
Disease control CompletedThe EMPIRE study confirms the technical performance of the new IMPERIA Delivery System and evaluates the safety and efficacy of the entire ALLEGRA THV System. The primary endpoint is device success rate at 7 days (discharge from index procedure or 7 days post implant, whichever …
Phase: NA • Sponsor: NVT GmbH • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Major trial aims to settle best approach for precancerous esophagus condition
Disease control Recruiting nowThe purpose of this study is to learn the best approach to treating patients with known or suspected Barrett's esophagus by comparing endoscopic surveillance to endoscopic eradication therapy. To diagnose and manage Barrett's esophagus and low-grade dysplasia, doctors commonly u…
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Could a headset at home boost memory in dementia?
Symptom relief Recruiting nowThis project aims to examine the efficacy of remote, caregiver-led tES/brain stimulation intervention targeted to improve memory, mobility, and executive functioning among older adults with mild cognitive impairment or mild dementia.
Phase: NA • Sponsor: Hebrew SeniorLife • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Can a good Night's sleep curb heavy drinking? new study says maybe
Symptom relief CompletedAlcohol use disorder (AUD) inflicts enormous physical, emotional, and financial burdens on the individual and society at large. Insomnia is highly prevalent among individuals with AUD, and disrupted sleep contributes substantially to alcohol-related problems. While research sugge…
Phase: NA • Sponsor: Jessica Weafer • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
Eye drops could make fuchs surgery less invasive
Disease control Recruiting nowDescemet Endothelial Thickness Comparison Trial (DETECT) II is a multi-center, outcome assessor-masked, placebo-controlled clinical trial randomizing 60 patients with Fuchs endothelial dystrophy to DMEK versus Descemet Stripping Only (DSO) with adjunctive Ripasudil.
Phase: PHASE3 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New HIV vaccine shows promise in early human trial
⭐️ VACCINE ⭐️ CompletedThis is an open-label Phase 1 study to examine the safety and immunogenicity of the CH505 TF chTrimer vaccine with 3M-052-AF +/- Alum adjuvant in healthy adults. The primary hypothesis is that the CH505 TF chTrimer will expand CH103-like B-cell precursors. HVTN 300 Part A examin…
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:07 UTC
-
Could blocking growth hormone ease severe insulin resistance?
Disease control Recruiting nowBackground: Lipodystrophy (LD) syndromes are a group of rare disorders that affect how a person s body can store and use fat tissue. Many people with LDs become severely insulin resistant. Some people are insulin resistant because of a variant in the insulin receptor gene. Insul…
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC